JP2002541233A5 - - Google Patents

Download PDF

Info

Publication number
JP2002541233A5
JP2002541233A5 JP2000610814A JP2000610814A JP2002541233A5 JP 2002541233 A5 JP2002541233 A5 JP 2002541233A5 JP 2000610814 A JP2000610814 A JP 2000610814A JP 2000610814 A JP2000610814 A JP 2000610814A JP 2002541233 A5 JP2002541233 A5 JP 2002541233A5
Authority
JP
Japan
Prior art keywords
embedded image
image embedded
alkyl
compound
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000610814A
Other languages
English (en)
Other versions
JP2002541233A (ja
Filing date
Publication date
Priority claimed from IT1999MI000753A external-priority patent/IT1311924B1/it
Application filed filed Critical
Publication of JP2002541233A publication Critical patent/JP2002541233A/ja
Publication of JP2002541233A5 publication Critical patent/JP2002541233A5/ja
Pending legal-status Critical Current

Links

Description

【特許請求の範囲】
【請求項1】 一般式(I)を有する化合物又はその塩:
A-B-C-N(O)2 (I)
[式中、
Aは、以下の基:
【化1】
Figure 2002541233
【化2】
Figure 2002541233
【化3】
Figure 2002541233
【化4】
Figure 2002541233
【化5】
Figure 2002541233
から選択され;
Bは、以下の基:
【化6】
Figure 2002541233
から選択され;
Cは二価の-Tc-Y- 、ここでTc = (CO)またはOであり;
Yはアルキレンオキシ基 -R'O-ここでR'は線状または分枝状のC1-C20 アルキルである)]
【請求項2】 R'が、C 1 -C 6 アルキルである請求項1に記載の化合物。
【請求項3】 R'が、C 2 -C 4 アルキルである請求項1に記載の化合物。
【請求項4】 以下の:
【化7】
Figure 2002541233
【化8】
Figure 2002541233
【化9】
Figure 2002541233
【化10】
Figure 2002541233
【化11】
Figure 2002541233
【化12】
Figure 2002541233
【化13】
Figure 2002541233
【化14】
Figure 2002541233
から選択される請求項による化合物。
【請求項5】 請求項1〜4のいずれか1項による化合物又はその塩と賦形剤とを含む医薬組成物。
【請求項6】 酸化ストレス及び/又は内皮機能不全に関連した疾患の治療のために用いられる請求項5に記載の医薬組成物。
JP2000610814A 1999-04-13 2000-04-11 医薬化合物 Pending JP2002541233A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT1999MI000753A IT1311924B1 (it) 1999-04-13 1999-04-13 Composti farmaceutici.
IT99A000753 1999-04-13
PCT/EP2000/003234 WO2000061537A2 (en) 1999-04-13 2000-04-11 Pharmaceutical compounds

Publications (2)

Publication Number Publication Date
JP2002541233A JP2002541233A (ja) 2002-12-03
JP2002541233A5 true JP2002541233A5 (ja) 2009-07-02

Family

ID=11382686

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000610814A Pending JP2002541233A (ja) 1999-04-13 2000-04-11 医薬化合物

Country Status (21)

Country Link
US (2) US6869974B1 (ja)
EP (1) EP1169294B1 (ja)
JP (1) JP2002541233A (ja)
KR (2) KR20020005667A (ja)
CN (1) CN1230416C (ja)
AT (1) ATE380170T1 (ja)
AU (1) AU778989B2 (ja)
BR (1) BR0009702A (ja)
CA (1) CA2370412C (ja)
DE (1) DE60037313T2 (ja)
ES (1) ES2296616T3 (ja)
HU (1) HUP0203378A3 (ja)
IL (2) IL145601A0 (ja)
IT (1) IT1311924B1 (ja)
MX (1) MXPA01010210A (ja)
NO (1) NO20014927L (ja)
NZ (1) NZ514267A (ja)
PL (1) PL350777A1 (ja)
RU (1) RU2237657C2 (ja)
WO (1) WO2000061537A2 (ja)
ZA (1) ZA200108127B (ja)

Families Citing this family (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1288123B1 (it) 1996-09-04 1998-09-10 Nicox Sa Uso di nitroderivati per l'incontinenza urinaria
IT1303671B1 (it) * 1998-07-28 2001-02-23 Nicox Sa Sali dell'acido nitrico con farmaci attivi nel trattamento dipatologie del sistema respiratorio
US6852739B1 (en) * 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
IT1311924B1 (it) * 1999-04-13 2002-03-20 Nicox Sa Composti farmaceutici.
MXPA02006312A (es) 1999-12-23 2004-06-21 Nitromed Inc Inhibidores de ciclooxigenasa-2 nitrosilatados y nitrosados, composiciones y metodos para utilizarse.
DE60131537T2 (de) 2000-06-22 2008-10-23 Nitromed, Inc., Lexington Nitrosierte und nitrosylierte taxane, zubereitungen und methoden der verwendung
IT1319201B1 (it) * 2000-10-12 2003-09-26 Nicox Sa Farmaci per il diabete.
IT1319202B1 (it) 2000-10-12 2003-09-26 Nicox Sa Farmaci per le malattie a base infiammatoria.
DE60122939T2 (de) 2000-12-21 2007-01-11 Nitromed, Inc., Bedford Substituierte arylverbindungen als neue, cyclooxygenase-2-selektive inhibitoren, zusammensetzungen und verwendungsverfahren
PL206138B1 (pl) 2000-12-25 2010-07-30 Daiichi Sankyo Company Limiteddaiichi Sankyo Company Limited Kompozycja farmaceutyczna zawierająca aspirynę oraz zestaw i zastosowanie składników kompozycji
EP1219306A1 (en) * 2000-12-29 2002-07-03 Nicox S.A. Compositions comprising cyclodextrins and NO- releasing drugs
DE60233140D1 (de) 2001-05-02 2009-09-10 Nitromed Inc Nitrosiertes und nitrosyliertes nebivolol und seine metaboliten, zusammensetzungen und anwendungsverfahren
ITMI20010985A1 (it) * 2001-05-15 2002-11-15 Nicox Sa Farmaci per il morbo di alzheimer
SE0101702D0 (sv) 2001-05-15 2001-05-15 Ardenia Investments Ltd Novel potentiating compounds
DE10125883A1 (de) 2001-05-28 2002-12-12 Serumwerk Bernburg Ag Arzneimittel enthaltend einen Effektor des Glutathionmetabolismus zusammen mit alpha-Liponsäure im Rahmen der Nierenersatztherapie
ITMI20011240A1 (it) * 2001-06-13 2002-12-13 Nicox Sa Farmaci per le vasculopatie
ITMI20011307A1 (it) * 2001-06-21 2002-12-21 Nicox Sa Farmaci per l'epilessia
ITMI20011744A1 (it) * 2001-08-09 2003-02-09 Nicox Sa Farmaci per le vasculopatie
EP2319518A1 (en) 2002-02-04 2011-05-11 ALFAMA-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda. Use of CO-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases
CA2480832A1 (en) * 2002-04-05 2003-10-23 Nitromed, Inc. Nitric oxide donors, compositions and methods of use
EP1539185A4 (en) * 2002-05-02 2006-04-05 Osteoscreen Inc METHODS AND COMPOSITIONS FOR STIMULATING BONE GROWTH USING NITRIC OXIDE FREEZING BISPHOSPHONATE CONJUGATES
US7220749B2 (en) 2002-06-11 2007-05-22 Nitromed, Inc. Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
ITMI20021392A1 (it) * 2002-06-25 2003-12-29 Nicox Sa Forme farmaceutiche per la somministrazione orale di farmaci liquidi a temperatura ambiente dotate di migliore biodisponibilita'
ITMI20021399A1 (it) * 2002-06-25 2003-12-29 Nicox Sa Inibitori della cicloossigenasi 2
ITMI20021391A1 (it) 2002-06-25 2003-12-29 Nicox Sa Nitroderivati di inibitori della cicloossigenasi-2
US7163958B2 (en) 2002-07-03 2007-01-16 Nitromed Inc. Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
CA2493156A1 (en) 2002-07-29 2004-02-05 Nitromed, Inc. Cyclooxygenase-2 selective inhibitors, compositions and methods of use
CA2493618A1 (en) 2002-08-01 2004-02-12 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
ITMI20021861A1 (it) * 2002-08-29 2004-02-29 Nicox Sa Procedimento di sintesi di nitrossialchilesteri di acidi carbossilici, intermedi impiegabili in detto procedimento e loro preparazione.
WO2006066894A1 (en) * 2004-12-24 2006-06-29 Ctg Pharma S.R.L. Compounds for treating metabolic syndrome
US7166638B2 (en) 2003-05-27 2007-01-23 Nicox S.A. Statin derivatives
US7169805B2 (en) 2003-05-28 2007-01-30 Nicox S.A. Captopril derivatives
CN1809345A (zh) 2003-06-19 2006-07-26 尼科克斯公司 依那普利-硝基衍生物和相关化合物作为ace抑制剂用于治疗心血管疾病
AU2004260830B2 (en) * 2003-07-31 2010-04-29 Nicox S.A. Nitrooxy derivatives of losartan, valsatan, candesartan, telmisartan, eprosartan and olmesartan as angiotensin-II receptor blockers for the treatment of cardiovascular diseases
KR20060120677A (ko) * 2003-12-02 2006-11-27 니콕스 에스. 에이. 항고혈압제로서의 카베디롤의 니트로옥시유도체 및 다른베타차단제들
AU2005207037A1 (en) * 2004-01-22 2005-08-04 Nitromed, Inc. Nitrosated and/or nitrosylated compounds, compositions and methods of use
US7067659B2 (en) * 2004-04-23 2006-06-27 Duke University Reactive oxygen generating enzyme inhibitor with nitric oxide bioactivity and uses thereof
AU2005281359A1 (en) 2004-08-26 2006-03-16 Apparao Satyam Prodrugs and codrugs containing novel bio-cleavable disulfide linkers
TW200616604A (en) 2004-08-26 2006-06-01 Nicholas Piramal India Ltd Nitric oxide releasing prodrugs containing bio-cleavable linker
US9579298B2 (en) 2004-12-02 2017-02-28 Piotr Chomczynski Antioxidant dietary supplement compositions and methods for maintaining healthy skin
US20070122509A1 (en) * 2004-12-02 2007-05-31 Molecular Research Center, Inc. Antioxidant dietary supplement compositions and methods for maintaining healthy skin
US20090018091A1 (en) * 2005-08-02 2009-01-15 Nitromed, Inc. Nitric Oxide Enhancing Antimicrobial Compounds, Compositions and Methods of Use
KR101239344B1 (ko) 2006-05-19 2013-03-05 마리 케이 인코포레이티드 글리세릴 및 글리콜산 화합물
UA113841C2 (xx) * 2006-07-18 2017-03-27 Сірководневі похідні нестероїдних протизапальних лікарських засобів
KR101495520B1 (ko) 2006-07-18 2015-02-26 안티브 홀딩스 인크. 약제의 4-하이드록시티오벤즈아미드 유도체
TW200831079A (en) 2006-12-13 2008-08-01 Merck & Co Inc Angiotensin II receptor antagonists
US7709634B2 (en) * 2007-09-20 2010-05-04 Apotex Pharmachem Inc. Amorphous form of rifaximin and processes for its preparation
AU2009248057B2 (en) * 2008-05-13 2013-02-21 Genmedica Therapeutics Sl Salicylate conjugates useful for treating metabolic disorders
MD4009C2 (ro) * 2008-07-15 2010-08-31 Институт Химии Академии Наук Молдовы Utilizarea 1-metil-4-(N-metilaminobutil-4)-β-carbolinei în calitate de remediu antituberculos
US9085508B2 (en) 2008-09-24 2015-07-21 Oral Delivery Technology Ltd. Nitric oxide releasing amino acid ester compound, composition and method of use
US7807716B2 (en) * 2008-09-24 2010-10-05 Oral Delivery Technology Ltd. Nitric oxide amino acid ester compound, compositions for increasing nitric oxide levels and method of use
JP2012503606A (ja) * 2008-09-24 2012-02-09 ニトロジェニックス インコーポレイティッド 酸化窒素放出アミノ酸エステル化合物、組成物、および使用方法
EP2194048A1 (en) * 2008-12-02 2010-06-09 Dirk Sartor Nitrate esters for the treatment of vascular and metabolic diseases
AU2010224866C1 (en) * 2009-03-16 2015-01-15 Genmedica Therapeutics Sl Anti-inflammatory and antioxidant conjugates useful for treating metabolic disorders
US20100239552A1 (en) * 2009-03-16 2010-09-23 Genmedica Therapeutics Sl Combination Therapies for Treating Metabolic Disorders
US9162969B2 (en) 2009-09-15 2015-10-20 Dsm Ip Assets B.V. Nitrooxyesters, their preparation and use
US8771693B2 (en) 2009-10-27 2014-07-08 Beth Israel Deaconess Medical Center, Inc. Methods and compositions for the generation and use of conformation-specific antibodies
WO2011057386A1 (en) * 2009-11-13 2011-05-19 Oral Delivery Technology Ltd. Composition and prophylactic device for enhancing sexual performance or pleasure
IT1397212B1 (it) * 2009-12-29 2013-01-04 Flamma Spa Derivati di amminoalcoli e loro attivita' terapeutica
TW201204355A (en) 2010-06-02 2012-02-01 Cardiolynx Ag Nitrate derivatives of pioglitazone
CN102442908A (zh) * 2010-10-14 2012-05-09 天津药物研究院 制备萘普西诺的中间体及方法
GB201020811D0 (en) 2010-12-08 2011-01-19 Solvotrin Innovations Ltd Compounds
US8466197B2 (en) 2010-12-14 2013-06-18 Genmedica Therapeutics Sl Thiocarbonates as anti-inflammatory and antioxidant compounds useful for treating metabolic disorders
ES2656237T3 (es) 2011-04-19 2018-02-26 Alfama, Inc. Moléculas liberadoras de monóxido de carbono y usos de las mismas
US10487114B2 (en) 2011-04-27 2019-11-26 Beth Israel Deaconess Medical Center, Inc. Methods for administering peptides for the generation of effective c/s conformation-specific antibodies to a human subject in need thereof
JP6134710B2 (ja) 2011-07-21 2017-05-24 アルファーマ インコーポレイテッドAlfama,Inc. 一酸化ルテニウム放出分子およびその使用
EP2967045B1 (en) 2013-03-12 2019-06-26 Mary Kay, Inc. Preservative system
WO2015023675A2 (en) 2013-08-12 2015-02-19 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
KR20160088436A (ko) * 2013-12-13 2016-07-25 코나리스 리써치 인스티튜트 아게 니코틴아미드 및 5-아미노살리실산의 조합을 포함하는, 장내 세균총에 유익한 영향을 미치거나 및/또는 위장 염증을 치료하기 위한 약학 조성물
WO2015095391A1 (en) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
WO2015100225A1 (en) 2013-12-27 2015-07-02 Novus International Inc. Ethoxylated surfactants
WO2016010771A1 (en) 2014-07-17 2016-01-21 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
ES2632808T3 (es) 2014-09-04 2017-09-15 Nicox Science Ireland Compuestos de carnosina donadores de óxido nítrico
JP2017531026A (ja) 2014-10-20 2017-10-19 ファーマシューティカル マニュファクチュアリング リサーチ サービシズ,インコーポレーテッド 徐放性乱用抑止性液体充填剤形
CN104478727A (zh) * 2014-12-22 2015-04-01 江西本草天工科技有限责任公司 一种阿魏酸释放一氧化氮的衍生物及其用途
CN105061286B (zh) * 2015-09-08 2017-11-24 上海蓝木化工有限公司 一种炔基取代吡咯类化合物的合成方法
US10584306B2 (en) 2017-08-11 2020-03-10 Board Of Regents Of The University Of Oklahoma Surfactant microemulsions
WO2019035571A1 (ko) 2017-08-14 2019-02-21 주식회사 엘지화학 온도 조절 성능이 개선된 배터리 팩
EP3694527A4 (en) * 2017-10-09 2021-07-14 The Broad Institute, Inc. COMPOSITIONS AND METHODS OF COMBINATORIAL DRUG DISCOVERY IN NANOLITER DROPLETS
CN109942455A (zh) * 2019-03-10 2019-06-28 陕西科技大学 具有抗肿瘤活性的棉酚-依氟鸟氨酸席夫碱化合物及其合成方法
CN111087301B (zh) * 2019-12-23 2022-05-20 河南中医药大学 布洛芬咖啡酸酯的合成方法及其在制备免疫抑制药物中的应用
CN111087302B (zh) * 2019-12-23 2022-05-20 河南中医药大学 布洛芬阿魏酸酯的合成方法及其在制备免疫抑制药物中的应用
JP7171971B1 (ja) * 2020-12-24 2022-11-15 参天製薬株式会社 エピナスチン又はその塩と硫黄系抗酸化剤を含有する経皮投与用医薬組成物
CN115500355B (zh) * 2022-09-09 2024-02-09 广东省农业科学院果树研究所 利用Podophyllotoxin和Gentisic acid防治荔枝霜疫霉病
CN116375698B (zh) * 2023-06-05 2023-08-01 中国林业科学研究院林产化学工业研究所 具有靶向抗肿瘤活性的漆酚基异羟肟酸型hdac抑制剂及其制备方法和应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2964567D1 (en) 1978-12-21 1983-02-24 Lepetit Spa New 3h-naphtho(1,2-d)imidazoles, processes for preparing them, compounds for use as antiinflammatory and antimicrobial agents and compositions for that use containing them
IT1134458B (it) * 1980-11-26 1986-08-13 Real Sas Di Alberto Reiner Derivato della n-acetil-cisteina ad attivita' terapeutica,procedimento per la sua preparazione e relative composizioni farmaceutiche
IT1190987B (it) * 1982-09-07 1988-02-24 Pharma Edmond Srl Tioesteri dell'acido acetilsalicilico,procedimento per la loro preparazione e composizioni farmaceutiche che li conttengono
ES8609231A1 (es) * 1985-12-03 1986-09-01 Farmhispania Procedimiento de obtencion del n-acetil-3(2-(acetiloxi)ben- zoilmercapto)alanina
JPS6316177A (ja) * 1986-07-08 1988-01-23 Sanden Corp 容量可変型圧縮機
IT1213301B (it) * 1986-07-14 1989-12-20 Zambon Spa Composizioni per il trattamento del le sindromi da ischemia e riperfusione
IT1256345B (it) * 1992-08-20 1995-12-01 Esteri nitrici di derivati dell'acido 2-(2,6-di-alo-fenilammino) fenilacetico e procedimento per la loro preparazione
IT1256450B (it) 1992-11-26 1995-12-05 Soldato Piero Del Esteri nitrici con attivita' farmacologica e procedimento per la loro preparazione
WO1995009831A1 (en) 1993-10-06 1995-04-13 Nicox S.A. Nitric esters having anti-inflammatory and/or analgesic activity and process for their preparation
RU2145595C1 (ru) 1994-05-10 2000-02-20 Никокс С.А. Нитроксисоединения и фармацевтическая композиция на их основе, имеющие противовоспалительную, анальгетическую и антитромбоцитарную активности
IT1276071B1 (it) * 1995-10-31 1997-10-24 Nicox Ltd Compositi ad attivita' anti-infiammatoria
IT1288123B1 (it) * 1996-09-04 1998-09-10 Nicox Sa Uso di nitroderivati per l'incontinenza urinaria
AU2387997A (en) * 1997-04-18 1998-11-13 Klinge Pharma Gmbh Stabilized medicaments containing cysteinyl derivatives
IT1311924B1 (it) * 1999-04-13 2002-03-20 Nicox Sa Composti farmaceutici.
IT1311921B1 (it) * 1999-04-13 2002-03-20 Nicox Sa Composti farmaceutici.

Similar Documents

Publication Publication Date Title
JP2002541233A5 (ja)
RU2219167C2 (ru) N-замещенные аминотетралины как лиганды для рецептора y5 нейропептида y, полезные при лечении ожирения и других расстройств
JP2002060340A5 (ja)
JP2002502874A5 (ja)
JP2003531118A5 (ja)
JP2004533444A5 (ja)
JP2003523927A5 (ja)
CO5251404A1 (es) Compuestos antibioticos de azalida
BR0210122A (pt) Composto ou um sal farmaceuticamente aceitável do mesmo, método para o tratamento ou prevenção de uma doença, uso do composto ou de seu sal, e, método para preparar o mesmo
CY1111693T1 (el) Αντιιικοι παραγοντες
LU91145I2 (fr) FIROCOXIB facultativement sous forme d'un sel pharmaceutiquement acceptable (PREVICOX).
EP1602370A3 (en) Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
DE60104206D1 (de) Halbfeste arzneizubereitung enthaltend isotretinoin
JP2002332234A5 (ja)
RU2695274C3 (ru) Новые композиции и способы их стабилизации
JP2004507521A5 (ja)
JP2002527414A5 (ja)
KR950010892A (ko) 자궁 섬유증 억제 방법
JP2001514282A5 (ja)
JP2003502367A5 (ja)
RU2002100058A (ru) Кристаллические производные 1-метилкарбапенема
JP2002518502A5 (ja)
JP2003503449A5 (ja)
RU92004509A (ru) Замещенные фенилфенольные соединения, фармацевтическая композиция, способ получения
JP2002522501A5 (ja)